|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Fiduciary cash | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Commission, fees and other receivables | ||||||||||||||||||||
| Fiduciary receivables | ||||||||||||||||||||
| Reinsurance recoverable | ||||||||||||||||||||
| Prepaid reinsurance premiums | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Fixed assets, net | ||||||||||||||||||||
| Operating lease assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Amortizable intangible assets, net | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Fiduciary liabilities | ||||||||||||||||||||
| Losses and loss adjustment reserve | ||||||||||||||||||||
| Unearned premiums | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt less unamortized discount and debt issuance costs | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Deferred income taxes, net | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Common stock, par value $0.10 per share; authorized 560 shares; issued 359 shares and outstanding 327 shares at 2026, issued 357 shares and outstanding 336 shares at 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock, at cost 32 shares at 2026 and 21 shares at 2025 | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Non-controlling interests | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
